Patent · US Active

Method for qualitative identification and quantitative determination of caffeine in drug

US12352693B2 · kind B2 · utility

0Cited by
0References
1Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 27, 2021
Grant dateJul 8, 2025
Priority date
Expiry dateApr 18, 2044

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2021/3595
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method for qualitative identification and quantitative determination of caffeine in a drug. In the method, terahertz absorption coefficient spectra of drugs with different concentrations of caffeine are measured, from which the frequency points, amplitudes and peak areas of characteristic peaks of the drugs with different concentrations of caffeine are obtained as characteristic quantities. Concentration gradients are established between the concentrations and the characteristic quantities, respectively. The characteristic quantities are imported to the SVR model to establish a training set and a test set. Finally, the qualitative identification and quantitative analysis of caffeine in unknown drugs are achieved.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.